Medical cannabis: health insurers block reimbursements in Ticino

Context

TL;DR

• Health insurers are blocking medical cannabis reimbursements in Ticino
• Lack of federal guidelines causes treatment disparities for patients
• Monthly therapy costs range between 300 and 1,000 Swiss francs
• CanMedTicino is seeking legal action and federal intervention

Key facts

• Association President: Gennaro Ausiello
• Swiss medical users: Around 1,160 people
• Reimbursement rate: Only 11% of reported therapies
• Monthly cost range: 300 to 1,000 Swiss francs
• Regulation change: Doctors can prescribe since 2022
• Appeal deadline: Within 30 days of negative decision
• Affected conditions: Chronic pain, multiple sclerosis, spasticity

For weeks now, Gennaro Ausiello, president of the CanMedTicino association, has been gathering testimonies from Ticino patients using therapeutic cannabis. Many of them, after securing reimbursement for prescribed treatments from their doctors, have suddenly found their coverage blocked by health insurance providers. 'I was reimbursed for a therapy for a neurological condition that was working. Then, without explanation, the reimbursement was cut off,' Ausiello explains. Today, he is taking legal action against his own health insurance to reinstate coverage.

Interrupted therapies, health at risk

The issue affects patients with serious conditions such as chronic pain, multiple sclerosis, or spasticity. Many had regained stability through therapy, reducing symptoms or even returning to work. After the reimbursements stopped, they experienced a rapid deterioration in their health. 'There are disparities in the decisions made by health insurance providers, and as president of the association, I am collecting the stories of many patients,' Ausiello tells Ticinonews. Some cases have also been reported to local media, but the problem remains widespread and unresolved.

📊 Inconsistent federal rules

Since 2022, doctors in Switzerland have been able to prescribe cannabis for therapeutic purposes, but access to these treatments remains complicated. 'We are in a paradoxical situation: there are no uniform federal guidelines, and everything is left to the discretion of health insurance providers,' Ausiello points out. 'This leads to clear disparities: some 'minor' conditions have been reimbursed for years, while more serious ones receive no coverage at all. Even patients with similar conditions can receive entirely different decisions.'

Official figures

According to data provided by Federal Councillor Elisabeth Baume-Schneider in response to a parliamentary motion, around 1,160 people in Switzerland use cannabis for medical purposes. However, CanMedTicino estimates that the real number could be higher, as not all doctors report such therapies. Of the reported therapies, only 11% are partially or fully reimbursed. 'These reimbursements are granted on a case-by-case basis, based on approvals from health insurance providers, or through supplementary insurance coverage,' the response to the parliamentary motion states. Currently, no cannabis-based medications are included in the list of approved specialties, which would allow for reimbursement under mandatory basic health insurance.

Operational details

For Ticino patients using medical cannabis, the current situation means economic and health uncertainty. The lack of uniform federal regulations forces health insurance funds to decide on a case-by-case basis, often with opaque criteria. This creates disparities in treatment among patients with similar conditions, depending on their insurance provider.

Before and after: changes in the rules

Until 2022, access to medical cannabis in Switzerland was severely restricted and subject to extraordinary authorization procedures. Under the new regulations, any doctor can prescribe therapeutic cannabis, but financial coverage remains at the discretion of health insurance funds. Before 2022, patients had to submit individual requests to the FOPH, with long waiting times and low approval rates. Today, prescriptions are simpler, but financial coverage remains even more uncertain.

Monthly costs

The cost of a medical cannabis treatment can range from 300 to 1,000 Swiss francs per month, depending on dosage and method of administration. For many patients, this expense is unsustainable without reimbursement from their health insurance. 'The issue is no longer the medical prescription, but the monthly cost and the uncertainty of health insurance decisions,' explains Ausiello. Some patients are forced to discontinue therapy for financial reasons, with immediate consequences for their health.

📊 Concrete cases in Ticino and Lombardy

Ausiello notes that many Ticino patients turn to doctors in Lombardy to obtain more affordable prescriptions and purchases, but even in these cases, Swiss health insurance coverage remains uncertain. 'Behind every rejected application isn’t just a number—it’s a person who goes back to suffering,' he says. Cross-border healthcare mobility, already complicated for other treatments, becomes even more problematic when it comes to medical cannabis.

Tables: Medical cannabis reimbursement in Ticino

What patients are asking for

The CanMedTicino association is calling for federal intervention to establish uniform criteria and provide greater security for patients. 'We’re not asking for privileges, but transparency and therapeutic continuity,' concludes Ausiello. The lack of certainty is pushing many patients to seek alternative, often illegal, routes to obtain the therapy they need. This poses an additional public health risk and an ethical dilemma for the Swiss healthcare system.

💡 Key takeaway

The new regulations have simplified medical cannabis prescriptions, but financial uncertainty persists, leaving patients vulnerable and forcing some to turn to unregulated sources. A clear federal framework is urgently needed to ensure fair and consistent access to this treatment.

⚠️ Call to action

Patients and advocates are urging policymakers to address this gap, emphasizing that medical cannabis should be treated like any other prescribed therapy—with predictable costs and reliable coverage.

Useful tools to protect your net income

To reduce FX leakage, compare CHF-EUR exchange options and banks for cross-border workers.

Key points

For Ticino patients who find themselves without coverage for medical cannabis, there are several practical options to address the situation. The first step is to verify the reason behind the health insurance company's refusal to reimburse the costs. Often, decisions are not provided in writing, so it is advisable to request the official documentation.

Step 1: Request the written reason

If the health insurance company has stopped reimbursing the costs, send a formal request to obtain the detailed reasoning. Without this documentation, contesting the decision will be difficult. The request can be submitted via registered letter or through the health insurance company's online portal. It is recommended to attach any medical prescriptions and reports that confirm the necessity of the therapy.

Step 2: Assess supplementary insurance

Some health insurance companies offer partial reimbursements through supplementary insurance policies. It is worth checking whether your policy includes this coverage and, if not, considering the activation of an additional policy. However, the additional costs can be significant and may not be affordable for all patients.

Step 3: Formal appeal

If the reimbursement is denied, it is possible to file an appeal with the insurance court. Ausiello himself is currently in a legal dispute with his health insurance company to regain coverage. The appeal must be submitted within 30 days of receiving the negative decision. It is advisable to seek assistance from a lawyer specializing in health insurance law, although the costs can be high.

Step 4: Alternative supply sources

Some patients turn to pharmacies abroad, particularly in Italy, where costs are lower. However, it is important to verify the legality of importing the product and ensure that it meets Swiss standards. Alternatively, some patient associations offer support for purchasing at reduced prices.

Step 5: Report your case to CanMedTicino

Ausiello encourages patients in this situation to report their case to the association to gather data and apply pressure on federal authorities. 'Every testimony counts,' he says. You can contact CanMedTicino through the official website or social media channels to receive support and updated information.

💡 Practical tip: Before discontinuing therapy, evaluate all available appeal and support options. Health cannot wait for bureaucratic decisions.

Deadlines and useful documents

There is no single deadline for filing appeals, but it is crucial to act promptly after the reimbursement refusal. The necessary documents include:

• Medical prescription for the therapy
• Written decision from the health insurance company
• Any medical reports confirming the necessity of the therapy

For further information and support, visit the CanMedTicino website or contact the association directly through official channels. If the therapy is urgent, consult your doctor to explore temporary alternatives, even in collaboration with the Ticino health service.

First day as a cross-border worker? Our practical guide walks you from cantonal registration to your first paycheck.

Source: ticinonews.ch